These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 37773310)

  • 1. A multimodal radiomic machine learning approach to predict the LCK expression and clinical prognosis in high-grade serous ovarian cancer.
    Zhan F; He L; Yu Y; Chen Q; Guo Y; Wang L
    Sci Rep; 2023 Sep; 13(1):16397. PubMed ID: 37773310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a prediction model for gross residual in high-grade serous ovarian cancer by combining preoperative assessments of abdominal and pelvic metastases and multiparametric MRI.
    Lu J; Cai S; Wang F; Wu PY; Pan X; Qiang J; Li H; Zeng M
    Acad Radiol; 2023 Sep; 30(9):1823-1831. PubMed ID: 36587996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of platinum resistance for advanced high-grade serous ovarian carcinoma using MRI-based radiomics nomogram.
    Li H; Cai S; Deng L; Xiao Z; Guo Q; Qiang J; Gong J; Gu Y; Liu Z
    Eur Radiol; 2023 Aug; 33(8):5298-5308. PubMed ID: 36995415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Noninvasive prediction of residual disease for advanced high-grade serous ovarian carcinoma by MRI-based radiomic-clinical nomogram.
    Li H; Zhang R; Li R; Xia W; Chen X; Zhang J; Cai S; Li Y; Zhao S; Qiang J; Peng W; Gu Y; Gao X
    Eur Radiol; 2021 Oct; 31(10):7855-7864. PubMed ID: 33864139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphocyte-specific kinase expression is a prognostic indicator in ovarian cancer and correlates with a prominent B cell transcriptional signature.
    Hinchcliff E; Paquette C; Roszik J; Kelting S; Stoler MH; Mok SC; Yeung TL; Zhang Q; Yates M; Peng W; Hwu P; Jazaeri A
    Cancer Immunol Immunother; 2019 Sep; 68(9):1515-1526. PubMed ID: 31515669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BTK Expression Level Prediction and the High-Grade Glioma Prognosis Using Radiomic Machine Learning Models.
    Jiang C; Sun C; Wang X; Ma S; Jia W; Zhang D
    J Imaging Inform Med; 2024 Aug; 37(4):1359-1374. PubMed ID: 38381384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of an ultrasound‑based radiomics nomogram to predict lymph node status in patients with high-grade serous ovarian cancer: a retrospective analysis.
    Qi Y; Liu J; Wang X; Zhang Y; Li Z; Qi X; Huang Y
    J Ovarian Res; 2024 Feb; 17(1):48. PubMed ID: 38389075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A CT-based radiomics nomogram for predicting early recurrence in patients with high-grade serous ovarian cancer.
    Chen HZ; Wang XR; Zhao FM; Chen XJ; Li XS; Ning G; Guo YK
    Eur J Radiol; 2021 Dec; 145():110018. PubMed ID: 34773830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a radiomic-clinical nomogram for prediction of survival in patients with serous ovarian cancer.
    Hong Y; Liu Z; Lin D; Peng J; Yuan Q; Zeng Y; Wang X; Luo C
    Clin Radiol; 2022 May; 77(5):352-359. PubMed ID: 35264303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and Validation of a Preoperative Magnetic Resonance Imaging Radiomics-Based Signature to Predict Axillary Lymph Node Metastasis and Disease-Free Survival in Patients With Early-Stage Breast Cancer.
    Yu Y; Tan Y; Xie C; Hu Q; Ouyang J; Chen Y; Gu Y; Li A; Lu N; He Z; Yang Y; Chen K; Ma J; Li C; Ma M; Li X; Zhang R; Zhong H; Ou Q; Zhang Y; He Y; Li G; Wu Z; Su F; Song E; Yao H
    JAMA Netw Open; 2020 Dec; 3(12):e2028086. PubMed ID: 33289845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deep learning provides a new computed tomography-based prognostic biomarker for recurrence prediction in high-grade serous ovarian cancer.
    Wang S; Liu Z; Rong Y; Zhou B; Bai Y; Wei W; Wei W; Wang M; Guo Y; Tian J
    Radiother Oncol; 2019 Mar; 132():171-177. PubMed ID: 30392780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and validation of an individualized gene expression-based signature to predict overall survival of patients with high-grade serous ovarian carcinoma.
    Yuan D; Zhu H; Wang T; Zhang Y; Zheng X; Qu Y
    Eur J Med Res; 2023 Oct; 28(1):465. PubMed ID: 37884970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computed tomography-based radiomics prediction of CTLA4 expression and prognosis in clear cell renal cell carcinoma.
    He H; Jin Z; Dai J; Wang H; Sun J; Xu D
    Cancer Med; 2023 Mar; 12(6):7627-7638. PubMed ID: 36397666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of a preoperative CT-based radiomic nomogram to predict pathology invasiveness in patients with a solitary pulmonary nodule: a machine learning approach, multicenter, diagnostic study.
    Huang L; Lin W; Xie D; Yu Y; Cao H; Liao G; Wu S; Yao L; Wang Z; Wang M; Wang S; Wang G; Zhang D; Yao S; He Z; Cho WC; Chen D; Zhang Z; Li W; Qiao G; Chan LW; Zhou H
    Eur Radiol; 2022 Mar; 32(3):1983-1996. PubMed ID: 34654966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiomic signature-based nomogram to predict disease-free survival in stage II and III colon cancer.
    Yao X; Sun C; Xiong F; Zhang X; Cheng J; Wang C; Ye Y; Hong N; Wang L; Liu Z; Meng X; Wang Y; Tian J
    Eur J Radiol; 2020 Oct; 131():109205. PubMed ID: 32871292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cox-LASSO Analysis Reveals a Ten-lncRNA Signature to Predict Outcomes in Patients with High-Grade Serous Ovarian Cancer.
    Xu L; Wu Y; Che X; Zhao J; Wang F; Wang P; Qu X; Liu Y; Li Z
    DNA Cell Biol; 2019 Dec; 38(12):1519-1528. PubMed ID: 31657627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Comprehensive Analysis of Prognostic Indicators in Serous Ovarian Cancer Based on Leukocyte Migration and Immune Microenvironment.
    Pan J; Chen X; Yang L; Song Y; Liu J; Li L; Lin Y; Tang L; Qiu S; Xu Q
    Front Biosci (Landmark Ed); 2023 Jun; 28(6):130. PubMed ID: 37395023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiomic model to predict the expression of PD-1 and overall survival of patients with ovarian cancer.
    Gao L; Jiang W; Yue Q; Ye R; Li Y; Hong J; Zhang M
    Int Immunopharmacol; 2022 Dec; 113(Pt A):109335. PubMed ID: 36279669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiomic nomogram based on MRI to predict grade of branching type intraductal papillary mucinous neoplasms of the pancreas: a multicenter study.
    Cui S; Tang T; Su Q; Wang Y; Shu Z; Yang W; Gong X
    Cancer Imaging; 2021 Mar; 21(1):26. PubMed ID: 33750453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of a CT-based radiomic nomogram for preoperative prediction of early recurrence in advanced gastric cancer.
    Zhang W; Fang M; Dong D; Wang X; Ke X; Zhang L; Hu C; Guo L; Guan X; Zhou J; Shan X; Tian J
    Radiother Oncol; 2020 Apr; 145():13-20. PubMed ID: 31869677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.